Comparative Evaluation of CLIA and ELISA Serological Assays for HSV‐1 IgG With Western Blot Confirmation in a Clinical Cohort: A Cross‐Sectional Study
Health Science Reports · 2026-10 · 9 (10)
DOI: 10.1002/hsr2.73366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 08.10.2026. Verfasst von Farah Issa und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, College of Health Sciences Qatar University Doha Qatar. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background and Aims Herpes simplex virus type 1 (HSV‐1) is highly prevalent worldwide, making accurate serological testing essential for both clinical diagnosis and epidemiological surveillance. Automated chemiluminescent immunoassays (CLIAs) offer operational advantages over enzyme‐linked immunosorbent assays (ELISAs); however, their diagnostic performance relative to Western blot (WB) confirmation in high‐prevalence settings remains insufficiently characterized. The comparative diagnostic accuracy of CLIA‐ and ELISA‐based assays for HSV‐1 IgG detection, when benchmarked against a WB reference standard in endemic populations, remains unclear. This study aimed to evaluate HSV‐1 IgG seroprevalence and diagnostic performance of one CLIA and two ELISA platforms using Western blot as the reference method.
Methods
Four hundred archived serum samples from adult male craft and manual workers in Qatar were tested using the Mindray CL‐900i CLIA, HerpeSelect ELISA, NovaLisa ELISA, and Euroimmun Western blot. Seroprevalence, diagnostic accuracy, and interassay agreement were assessed using WB as the reference standard, with equivocal and indeterminate results excluded from analysis.
Results
HSV‐1 IgG seroprevalence estimates were comparable across assays: HerpeSelect 72.5% (290/400), Mindray 70.3% (281/400), NovaLisa 66.3% (265/400), and Western blot 57.8% (231/400), with no statistically significant differences (all p > 0.05). The Mindray CLIA demonstrated the highest diagnostic performance (sensitivity 95.7%, specificity 88.9%, accuracy 93.4%) and strong agreement with Western blot ( κ = 0.85). HerpeSelect showed substantial agreement ( κ = 0.81), while NovaLisa exhibited lower specificity.
Conclusion
CLIA‐ and ELISA‐based assays produced comparable HSV‐1 seroprevalence estimates in this high‐prevalence population; however, diagnostic accuracy varied across platforms. The CLIA platform demonstrated the strongest agreement with Western blot, supporting its use in high‐throughput settings, while confirmatory testing remains important to minimize misclassification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Science, College of Health Sciences Qatar University Doha Qatar.
- Biomedical Research Center Qatar University Doha Qatar.
- Mathematics Program, Department of Mathematics and Statistics, College of Arts and Sciences Qatar University Doha Qatar.
- Department of Immunopathology, Princess Iman Bint Abdullah II Center for Research and Laboratory Sciences Royal Medical Services Amman Jordan.
- Department of Experimental Medicine University of Rome Tor Vergata Rome Italy.
- Saint Camillus International University of Health Sciences Rome Italy.
ORCID-Profile: Farah Trad, Nouran Zein, Shaden Abunasser, Israa Salameh, Houssein Ayoub, Massimo Pieri, Eleonora Nicolai, Hadi M Yassine, Laith J AbuRaddad, Gheyath K Nasrallah
Zitieren
APA
Issa, F., Trad, F., Zein, N., Abunasser, S., Nizamuddin, P. B., Salameh, I., Ayoub, H., Al-Abbadi, B., Al-Hiary, M., Abou-Nouar, Z., Al-Subeihi, O., Al-Zubi, Y., Al-Manaseer, A., Al-Jaloudi, A., Nasrallah, D. F., Younes, S., Younes, N., Abdallah, M., Pieri, M., …, & Nasrallah, G. K. (2026). Comparative Evaluation of CLIA and ELISA Serological Assays for HSV‐1 IgG With Western Blot Confirmation in a Clinical Cohort: A Cross‐Sectional Study. Health Science Reports, 9(10). https://doi.org/10.1002/hsr2.73366
Vancouver
Issa F, Trad F, Zein N, Abunasser S, Nizamuddin PB, Salameh I, et al. Comparative Evaluation of CLIA and ELISA Serological Assays for HSV‐1 IgG With Western Blot Confirmation in a Clinical Cohort: A Cross‐Sectional Study. Health Science Reports. 2026;9(10). doi:10.1002/hsr2.73366
BibTeX
@article{Issa2026,
author = {Issa, Farah and Trad, Farah and Zein, Nouran and Abunasser, Shaden and Nizamuddin, Parveen B and Salameh, Israa and Ayoub, Houssein and Al-Abbadi, Baheieh and Al-Hiary, Mansour and Abou-Nouar, Zain and Al-Subeihi, Oraib and Al-Zubi, Yaser and Al-Manaseer, Ahmad and Al-Jaloudi, Anwar and Nasrallah, Dana F and Younes, Salma and Younes, Nadin and Abdallah, Marah and Pieri, Massimo and Nicolai, Eleonora and Yassine, Hadi M and AbuRaddad, Laith J and Nasrallah, Gheyath K},
title = {Comparative Evaluation of CLIA and ELISA Serological Assays for HSV‐1 IgG With Western Blot Confirmation in a Clinical Cohort: A Cross‐Sectional Study},
journal = {Health Science Reports},
year = {2026},
volume = {9},
number = {10},
doi = {10.1002/hsr2.73366}
}
EUVIMED